Published in J Clin Pathol on December 03, 2010
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Breast Cancer Res Treat (2013) 1.34
Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy. J Interferon Cytokine Res (2013) 1.07
The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831. Breast Cancer Res (2015) 0.82
HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis. J Gastrointest Oncol (2014) 0.81
Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population. PLoS One (2015) 0.76
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell (2011) 2.78
Digital pathology: exploring its applications in diagnostic surgical pathology practice. Pathology (2010) 2.05
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Hepatol (2008) 1.87
Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res (2013) 1.67
A molecular classification of papillary renal cell carcinoma. Cancer Res (2005) 1.60
Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J Biol Chem (2003) 1.58
Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol (2003) 1.55
Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma. Urology (2010) 1.52
Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Clin Cancer Res (2004) 1.44
Diagnostic issues in second opinion consultations in prostate pathology. Pathology (2010) 1.42
A rare case of localised AA-type amyloidosis of the ureter with spheroids of amyloid. Singapore Med J (2012) 1.39
Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol (2011) 1.38
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol (2009) 1.32
Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance. Am J Clin Pathol (2010) 1.29
Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours. Breast (2012) 1.27
Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers. Am J Surg Pathol (2010) 1.25
Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. J Mol Diagn (2012) 1.21
Solid pseudopapillary tumour of the pancreas. ANZ J Surg (2003) 1.19
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol (2014) 1.11
The pathology of dengue hemorrhagic fever. Semin Diagn Pathol (2007) 1.10
Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer (2010) 1.08
Recurrent phyllodes tumours of the breast: pathological features and clinical implications. ANZ J Surg (2006) 1.06
Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer. Breast Cancer Res Treat (2012) 1.06
Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors. Breast (2010) 1.04
A functional module of yeast mediator that governs the dynamic range of heat-shock gene expression. Genetics (2006) 1.04
Spindle cell lesions of the breast--the pathologic differential diagnosis. Breast Cancer Res Treat (2007) 1.03
c-erbB-2 (HER-2/neu) immunohistochemistry in invasive breast cancer: is there concordance between standard sections and tissue microarrays? Pathology (2006) 1.01
A molecular signature of the Nottingham prognostic index in breast cancer. Cancer Res (2004) 1.01
The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma. Cancer (2011) 1.00
p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Res (2012) 0.99
Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin Pract (2010) 0.99
DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest (2014) 0.97
Sclerosing polycystic adenosis of the parotid gland: report of a bifocal, paucicystic variant with ductal carcinoma in situ and pronounced stromal distortion mimicking invasive carcinoma. Head Neck Pathol (2011) 0.97
Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia. Cancer Genet Cytogenet (2005) 0.96
Mixed epithelial and stromal tumour (MEST) of the kidney: a clinicopathological report of three cases. Pathology (2009) 0.96
TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin Cancer Res (2012) 0.95
Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Am J Clin Pathol (2007) 0.94
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Mod Pathol (2010) 0.94
Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer. Histopathology (2012) 0.94
Primary pleural synovial sarcoma. A case report and review of the literature. Arch Pathol Lab Med (2003) 0.94
Atypia in inverted urothelial papillomas: pathology and prognostic significance. Hum Pathol (2004) 0.93
Sarcomatoid renal cell carcinoma metastatic to the breast: report of a case with diagnosis on fine needle aspiration cytology. Acta Cytol (2007) 0.93
Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms. Histopathology (2010) 0.93
Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers. Ann Surg Oncol (2014) 0.91
Targets of genome copy number reduction in primary breast cancers identified by integrative genomics. Genes Chromosomes Cancer (2007) 0.91
TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery. Pathology (2008) 0.91
Flat epithelial atypia: concepts and controversies of an intraductal lesion of the breast. Pathology (2005) 0.91
Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing. J Clin Oncol (2011) 0.90
Juxtaglomerular cell tumor: a morphological, immunohistochemical and genetic study of six cases. Hum Pathol (2012) 0.90
Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res (2012) 0.90
Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT. J Photochem Photobiol B (2005) 0.89
EGFR mutation testing practices within the Asia Pacific region: results of a multicenter diagnostic survey. J Thorac Oncol (2015) 0.88
Breast carcinoma in women 35 years and younger: a pathological study. Pathology (2006) 0.88
BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy. Cancer Epidemiol Biomarkers Prev (2007) 0.88
Novel photodynamic diagnosis of bladder cancer: ex vivo fluorescence cytology using hypericin. Int J Oncol (2003) 0.87
GST-pi expression correlates with oxidative stress and apoptosis in breast cancer. Oncol Rep (2004) 0.87
Mucin extravasation in breast core biopsies--clinical significance and outcome correlation. Histopathology (2009) 0.87
Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle. Int J Oncol (2010) 0.87
Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cells. J Biol Chem (2010) 0.87
Dasatinib induces a response in malignant thymoma. J Clin Oncol (2006) 0.86
Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer. Breast Cancer Res Treat (2015) 0.86
Ductal carcinoma in situ within phyllodes tumour: a rare occurrence. Pathology (2005) 0.86
Breast cancer stem cells: an update. J Clin Pathol (2013) 0.86
Breast cancer in Singapore: some perspectives. Breast Cancer (2009) 0.86
In vivo liver electroporation: optimization and demonstration of therapeutic efficacy. Hum Gene Ther (2006) 0.85
Independent component analysis of dynamic contrast-enhanced magnetic resonance images of breast carcinoma: a feasibility study. J Magn Reson Imaging (2008) 0.85
Low-grade adenosquamous carcinoma of the breast. J Clin Pathol (2012) 0.85
Biopsy sampling of breast lesions: comparison of core needle- and vacuum-assisted breast biopsies. Breast Cancer Res Treat (2011) 0.85
Clinical validation of a customized multiple signature microarray for breast cancer. Clin Cancer Res (2008) 0.85
Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer. Histopathology (2014) 0.84
Intravascular lymphomatosis of the lung and liver following eyelid lymphoma in a Chinese man and review of primary pulmonary intravascular lymphomatosis. Pathology (2002) 0.84
CX3CL1 expression is associated with poor outcome in breast cancer patients. Breast Cancer Res Treat (2013) 0.84
A unique case of spontaneous regression of metastatic papillary renal cell carcinoma: a case report. Cases J (2009) 0.84
Phyllodes tumours of the breast - differentiating features in core needle biopsy. Histopathology (2011) 0.84
Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in Singapore. Chin Med J (Engl) (2013) 0.84
Early detection of breast cancer through population-based mammographic screening in Asian women: a comparison study between screen-detected and symptomatic breast cancers. Breast J (2009) 0.83
Fluorescence detection of bladder cancer using urine cytology. Int J Oncol (2007) 0.83
Molecular pathogenesis of progression and recurrence in breast phyllodes tumors. Am J Transl Res (2009) 0.82
Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women. Pathology (2006) 0.82
Symptomatic renal leiomyoma: report of two cases. Pathology (2006) 0.82
Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma? BJU Int (2005) 0.82
Biomarkers in renal cancer. Virchows Arch (2014) 0.82
Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast Cancer. Arch Pathol Lab Med (2016) 0.81